Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment
NCT ID: NCT01610804
Last Updated: 2012-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
18 participants
OBSERVATIONAL
2011-04-30
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study hypothesis: Since exudative changes in the choroid seem to constitute the primary pathology of CSCR, changes in choroidal thickness compared to healthy eyes should be present and be visible using EDI-OCT.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Central Serous Chorioretinopathy Registry and Pachychoroid Observation and Natural History Study
NCT05278169
Central Serous Chorioretinopathy: Etiology, Course and Prognosis
NCT01378130
Prospective Exploratory Cohort Study on Ganglion Cell Degeneration in Retinitis Pigmentosa Patients
NCT07056738
Retinal Thickness and Volume Estimates Given by Time Domain and Spectral Optical Coherence Tomography
NCT00873106
Choroidal Thickness in Optic Neuropathy
NCT02382627
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CSCR-Patients
Patients suffering from Central Serous Chorioretinopathy
No interventions assigned to this group
Healthy Subjects
Healthy subjects with (assumed) normal choroidal thickness
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Regensburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Caroline Brandl
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria A Gamulescu, PD Dr. med.
Role: STUDY_CHAIR
University Hospital Regensburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Regensburg
Regensburg, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009 Nov-Dec;29(10):1469-73. doi: 10.1097/IAE.0b013e3181be0a83.
Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009 May;147(5):811-5. doi: 10.1016/j.ajo.2008.12.008. Epub 2009 Feb 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSCR2011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.